Hainan Poly Pharm News

Puli Pharmaceuticals: Announcement on the Company's Response to the Letter of Concern on the Shenzhen Stock Exchange

Apr 19 09:46 ET

Puli Pharmaceuticals: Announcement on receipt of a supervisory letter from an independent director

Apr 19 09:45 ET

Prednisolone Pharmaceuticals: Announcement on the marketing approval of voriconazole injections from the Norwegian Medicines Agency

Apr 17 06:12 ET

Puli Pharmaceuticals: Notice on receiving the Hainan Securities Regulatory Bureau's decision to order the company to take corrective administrative supervision measures

Apr 16 09:32 ET

Puri Pharmaceuticals: Notice on the US Food and Drug Administration (FDA) marketing approval for a supplementary application for new specifications for iopamol injections (intravascular administration)

Apr 11 06:19 ET

Prednisolone Pharmaceuticals: Announcement on obtaining marketing approval for voriconazole injections from the Finnish National Drug Administration

Apr 8 05:48 ET

Prednisolone Pharmaceuticals: Announcement on obtaining marketing approval for voriconazole injections from the Swedish Medicines Agency

Apr 7 12:00 ET

Puri Pharmaceuticals: Announcement on Daptomycin for injections obtained marketing approval from the German Federal Institute for Drugs and Medical Devices (BfArM)

Apr 3 06:20 ET

Puli Pharmaceuticals: Announcement on the change of signed accountant

Apr 3 06:18 ET

Puli Pharmaceuticals: Announcement on the conversion of convertible corporate bonds to shares in the first quarter of 2024

Apr 1 06:36 ET

Puli Pharmaceuticals: Announcement on the Company\'s Obtaining the “Pharmaceutical GMP Compliance Inspection Notice”

Apr 1 06:35 ET

Puri Pharmaceuticals: Announcement on obtaining marketing approval from the US Food and Drug Administration (FDA) for phenylephrine hydrochloride injections

Mar 18 04:48 ET

Puri Pharmaceuticals: Notice on submission of 8- (2-hydroxybenzamide) sodium caprylate (SNAC) pharmaceutical excipients to the U.S. DMF

Mar 14 06:32 ET

Puli Pharmaceuticals: Notice on obtaining marketing approval from the US Food and Drug Administration (FDA) for benzenesulfonium atracurium injection

Mar 10 12:00 ET

Puri Pharmaceuticals: Announcement on obtaining marketing approval for injectable pantoprazole sodium from the Department of Pharmacy of the Ministry of Health of Israel

Mar 5 02:58 ET

Prixetam: Announcement on the temporary approval of the US Food and Drug Administration (FDA) for bricetam injections

Mar 3 11:00 ET

Puli Pharmaceuticals: Announcement on obtaining marketing approval from the US Food and Drug Administration (FDA) for lacosamide injections

Feb 18 11:00 ET

Puri Pharmaceuticals: Announcement on obtaining marketing approval for sodium nitrate injections in Germany

Feb 6 06:27 ET

Puli Pharmaceuticals: Announcement on 2024 Interest Payments on Convertible Corporate Bonds

Feb 2 05:43 ET

Puli Pharmaceuticals: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders

Jan 26 04:52 ET